| Page 1786 | Kisaco Research
 

Marie Molde

Registered Dietician, Client Solutions
Datassential

Marie Molde

Registered Dietician, Client Solutions
Datassential

Marie Molde

Registered Dietician, Client Solutions
Datassential
 

Brooke Scheller

DCN, Head of Nutrition
Freshly

Brooke Scheller

DCN, Head of Nutrition
Freshly

Brooke Scheller

DCN, Head of Nutrition
Freshly
 

Alessandra Breschi

Postdoctoral Research Fellow
Genetics, Stanford University

Alessandra Breschi

Postdoctoral Research Fellow
Genetics, Stanford University

Alessandra Breschi

Postdoctoral Research Fellow
Genetics, Stanford University
 

Sherry Zhang

Founder and CEO
GenoPalate

Sherry is a mother, a scientist and an entrepreneur. Her passion and love for life and science has taken her far from Northern Asia to America, from studying bacteria, plants to populations of humans, and from researching obesity genetics as a medical college professor to founding GenoPalate, a company that provides a direct-to-consumer solution for eating uniquely based on genetics and biology for a healthier life. 

Sherry Zhang

Founder and CEO
GenoPalate

Sherry Zhang

Founder and CEO
GenoPalate

Sherry is a mother, a scientist and an entrepreneur. Her passion and love for life and science has taken her far from Northern Asia to America, from studying bacteria, plants to populations of humans, and from researching obesity genetics as a medical college professor to founding GenoPalate, a company that provides a direct-to-consumer solution for eating uniquely based on genetics and biology for a healthier life. 

 

Chris Mason

Co-Founder
Ongevity Health

Chris Mason

Co-Founder
Ongevity Health

Chris Mason

Co-Founder
Ongevity Health
 

Robert Miller

CEO
Phynova

Robert Miller

CEO
Phynova

Robert Miller

CEO
Phynova
 

Marco Lotti

CTO
Mixfit

Marco Lotti

CTO
Mixfit

Marco Lotti

CTO
Mixfit
 

Dr Angeliki Grammenos

RA Manager
Celyad

Angeliki has held positions in academia and biopharma, with a special focus in cell therapy.

Angeliki is a physicist by training and has a PhD in biophysics specialized in cell biology. She left her teaching position at the University of Liège in 2012, to join the international office of Doctors Without Borders where she assisted the Ethical review board as well as the Quality Assurance department of the movement.

Dr Angeliki Grammenos

RA Manager
Celyad

Dr Angeliki Grammenos

RA Manager
Celyad

Angeliki has held positions in academia and biopharma, with a special focus in cell therapy.

Angeliki is a physicist by training and has a PhD in biophysics specialized in cell biology. She left her teaching position at the University of Liège in 2012, to join the international office of Doctors Without Borders where she assisted the Ethical review board as well as the Quality Assurance department of the movement.

In 2015, she joined Bone Therapeutics S.A, a biopharmaceutical company dedicated to the development of cell therapy products based on autologous and allogeneic adult stem cell technology to treat unmet medical needs in the field of bone disease where she led the RA Department.

In 2018, Angeliki joined Celyad, a biopharmaceutical company specialized in autologous and allogeneic cell therapy. Celyad’s core business lies in immune-oncology and the development of NK-receptor based CAR T therapies.

Q&A - Manfred Koegl - Boehringer Ingelheim